Multicentric plasmocytic Castleman's disease with polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome and coexistent human herpes virus-6 infection -A possible relationship

Leukemia and Lymphoma

Volumn 50, Issue 10, 2009, Pages 1661-1665

  Fazakas, Ád́m ^a   Csire, Márta ^b   Berencsi, György ^b   Szepesi, Ágota ^a   Matolcsy, András ^a   Jakab, Lajos ^a   Karádi, István ^a   Várkonyi, Judit ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b Department of Virology   (Hungary)

Author keywords

Castleman's disease; HHV 6; POEMS syndrome

Indexed keywords

IMMUNOGLOBULIN; M PROTEIN; METHOTREXATE; PREDNISONE; THYROGLOBULIN ANTIBODY; THYROTROPIN; THYROXINE; VIRUS DNA; VITAMIN B COMPLEX;

AGED; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; ATAXIA; AUTOIMMUNE THYROIDITIS; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DIZZINESS; DYSPHAGIA; ELECTROMYOGRAM; ELECTRONYSTAGMOGRAPHY; FATIGUE; FEMALE; FLOW CYTOMETRY; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HORMONE DETERMINATION; HUMAN; HUMAN HERPESVIRUS 6; HYPOTHYROIDISM; IMMUNE RESPONSE; LIMB WEAKNESS; LOW DRUG DOSE; LYMPH NODE; MUSCLE BIOPSY; PAIN; PARESTHESIA; PHYSICAL EXAMINATION; POEMS SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY; STEROID THERAPY; THERAPY EFFECT; THYROGLOBULIN BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR VOLUME; VIRUS DETECTION; X RAY ANALYSIS;

AGED; B-LYMPHOCYTES; BONE MARROW; DNA, VIRAL; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 6, HUMAN; HUMANS; LYMPH NODES; METHOTREXATE; PARAPROTEINS; POEMS SYNDROME; PREDNISONE; ROSEOLOVIRUS INFECTIONS; THYROIDITIS, AUTOIMMUNE; VITAMIN B COMPLEX;

EID: 70350749628     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190903162743     Document Type: Article

References (18)

1. Castleman B, Thowne VW. Case records of the Massachusetts general hospital weekly clinicopathological exercises: Case 40011. NEJM 1954;250:26-30.
2. Casper C. The aetiology and management of Castelman disease at 50 years: Translating pathophysiology to patient care. Brit J Haematol 2005;129:3-17.
3. Dispenzieri A, Kyle RA, Lacy MQ, et al. POEMS syndrome: Definitions and long-term outcome. Blood 2003;101:2496-2506.
4. KojimaM,NakamuraN, Tsukamoto N, et al. Clinical implications of idiopathic multicentric castleman disease among Japanese: A report of28cases. Int JSurgPathol 2008;16:391-398.
5. Waterston A, Bower M. Fifty years of multicentric Castelman's disease. Acta Oncol 2004;43:8:698-704.
6. Pozo F, Tenorio A. Detection and typing of lymphotropic herpesviruses by multiplex polimerase chain reaction. J Virol Meth 1999;79:9-19.
7. Keller AR, Hocholzer L, Castleman B. Hyalin-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670.
8. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-1367.
9. Hideshima T, Chauhan D, Teoh G, et al. Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin. Clin Cancer Res 2000;6:1180-1189.
10. Chadburn A, Cesarman E, Nador RG, Liu YF, Knowles DM. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer 1997;80: 788-797.
11. Wan X, Wang H, Nicholas J. Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J Virol 1999;73:8268-8278.
12. Aoki Y, Jaffe ES, Chang Y, et al. Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 1999;93:4034-4043.
13. Caserta MT, Mock DJ, Dewhurst S. Human herpes virus 6 emerging infections. CID 2001;33:833.
14. Razonable RR, Fanning C, Brown RA, et al. Selective reactivation of human herpesvirus 6 variant a occurs in critically ill immunocompetent hosts. JID 2002;185:110-113.
15. Mayne M, Cheadle C, Soldan SS, et al. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: Induction of proinflammatory mechanisms. J Virol 2001; 75:11641-11650.
16. Singh N, Husain S, Carrigan DR, et al. Impact of human herpesvirus-6 on the frequency and severity of recurrent hepatitis C virus hepatitis in liver transplant recipients. Clin Transplant 2002;16:92-96.
17. Gompels UA, Nicholas J, Lawrence G, et al. The DNA sequence of human herpesvirus-6: Structure, coding content, and genome evolution. Virology 1995;209:29-51.
18. Campadelli-Fiume G, Mirandola P, Menotti L. Human herpesvirus 6: An emerging pathogen. Emerg Infect Dis 2004;5:1-18.